Compare BLTE & AX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLTE | AX |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.4B |
| IPO Year | 2021 | 2004 |
| Metric | BLTE | AX |
|---|---|---|
| Price | $173.05 | $92.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $198.00 | $103.14 |
| AVG Volume (30 Days) | 198.1K | ★ 235.6K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.13 |
| EPS | N/A | ★ 8.48 |
| Revenue | N/A | ★ $81,254,000.00 |
| Revenue This Year | N/A | $24.76 |
| Revenue Next Year | $492.11 | $10.86 |
| P/E Ratio | ★ N/A | $11.00 |
| Revenue Growth | N/A | ★ 23.51 |
| 52 Week Low | $65.00 | $74.89 |
| 52 Week High | $200.00 | $105.74 |
| Indicator | BLTE | AX |
|---|---|---|
| Relative Strength Index (RSI) | 54.90 | 38.65 |
| Support Level | $167.80 | $91.90 |
| Resistance Level | $182.61 | $100.51 |
| Average True Range (ATR) | 7.90 | 2.00 |
| MACD | 2.18 | -0.44 |
| Stochastic Oscillator | 48.43 | 12.70 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Axos Financial Inc is a technology-driven, diversified financial services company. Its client-centric, technology-enabled services model provides secure and scalable banking, clearing and custody, and investment advisory solutions to retail and business customers. The Bank provides consumer and commercial banking products and services through its digital online and mobile banking platforms, low-cost distribution channels and affinity partners. It offers deposit and lending products to customers nationwide including consumer and business checking, savings, etc. Its segments are Banking Business Segment and the Securities Business Segment. Majority of income comes from Banking Business Segment- It distribute its loan products through its retail, correspondent and wholesale channels.